66 related articles for article (PubMed ID: 17679209)
21. [Early prediction of response to primary chemotherapy by sequential FDG -PET in patients with advanced breast cancer].
Momiyama N; Ishikawa T; Ichikawa Y; Shimada H; Katayama A; Ozawa Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():385-8. PubMed ID: 17679210
[No Abstract] [Full Text] [Related]
22. Oncological applications of FDG PET imaging.
Delbeke D
J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
[No Abstract] [Full Text] [Related]
23. PET imaging in breast cancer.
Bombardieri E; Crippa F
Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
[TBL] [Abstract][Full Text] [Related]
24. PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer.
Lei L; Wang X; Chen Z
Adv Clin Exp Med; 2016; 25(2):377-82. PubMed ID: 27627573
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET and beyond: molecular breast cancer imaging.
Quon A; Gambhir SS
J Clin Oncol; 2005 Mar; 23(8):1664-73. PubMed ID: 15755974
[No Abstract] [Full Text] [Related]
26. [Usefulness of 18F-FDG PET in the diagnosis for breast cancer patients].
Suzuki T; Uno K; Kubo A
Nihon Rinsho; 2006 Mar; 64(3):504-10. PubMed ID: 16529042
[TBL] [Abstract][Full Text] [Related]
27. Evolving role of positron emission tomography in breast cancer imaging.
Eubank WB; Mankoff DA
Semin Nucl Med; 2005 Apr; 35(2):84-99. PubMed ID: 15765372
[TBL] [Abstract][Full Text] [Related]
28. Should FDG PET/CT be used for the initial staging of breast cancer?
Groheux D; Hindié E; Rubello D; Espié M; Baillet G; Giacchetti S; Misset JL; Moretti JL
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1539-42. PubMed ID: 19449002
[No Abstract] [Full Text] [Related]
29. Fluorodeoxyglucose-PET in the management of breast cancer.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
[TBL] [Abstract][Full Text] [Related]
30. Hybrid PET-dynamic CECT in the management of breast cancer.
Kumar R; Das CJ
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):413-5. PubMed ID: 19153731
[No Abstract] [Full Text] [Related]
31. [FDG (18 fluorodeoxyglucose) positron emission tomography and breast cancer].
Rouëssé J; Alberini JL; Wartski M; Gutman F; Collignon MA; Corone C; Pichon MF; Pecking AP
Bull Acad Natl Med; 2005 May; 189(5):963-75; discussion 975-8. PubMed ID: 16433466
[TBL] [Abstract][Full Text] [Related]
32. The value of FDG positron emission tomography in the management of patients with breast cancer.
Weir L; Worsley D; Bernstein V
Breast J; 2005; 11(3):204-9. PubMed ID: 15871707
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of colorectal cancer with FDG-PET].
Uno K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
[No Abstract] [Full Text] [Related]
34. Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.
Sanz-Viedma S; Torigian DA; Parsons M; Basu S; Alavi A
Rev Esp Med Nucl; 2009; 28(3):159-66. PubMed ID: 19558958
[No Abstract] [Full Text] [Related]
35. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases.
Isasi CR; Moadel RM; Blaufox MD
Breast Cancer Res Treat; 2005 Mar; 90(2):105-12. PubMed ID: 15803356
[TBL] [Abstract][Full Text] [Related]
36. Role of positron-emission tomography scan in the diagnosis and management of breast cancer.
Almubarak M; Osman S; Marano G; Abraham J
Oncology (Williston Park); 2009 Mar; 23(3):255-61. PubMed ID: 19418826
[TBL] [Abstract][Full Text] [Related]
37. FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations.
Lim HS; Yoon W; Chung TW; Kim JK; Park JG; Kang HK; Bom HS; Yoon JH
Radiographics; 2007 Oct; 27 Suppl 1():S197-213. PubMed ID: 18180227
[TBL] [Abstract][Full Text] [Related]
38. Molecular imaging using PET for breast cancer.
Kurihara H; Shimizu C; Miyakita Y; Yoshida M; Hamada A; Kanayama Y; Yonemori K; Hashimoto J; Tani H; Kodaira M; Yunokawa M; Yamamoto H; Watanabe Y; Fujiwara Y; Tamura K
Breast Cancer; 2016 Jan; 23(1):24-32. PubMed ID: 25917108
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography/computed tomography in locally advanced breast cancer.
Ozkan E
Exp Oncol; 2013 Dec; 35(4):253-7. PubMed ID: 24382434
[TBL] [Abstract][Full Text] [Related]
40. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
